Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Costanza, Mariantonia Dr. (1) Daniel, Peter Prof. Dr. (1) Diecke, Sebastian Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Kirchner, Marieluise Dr. (1) Kühn, Ralf Dr. (4) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Rathjen, Fritz Prof. Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) Uyar, Bora Dr. (1) Willnow, Thomas Prof. Dr. (1) Wollert-Wulf, Brigitte (2) (-) Hinze, Christian Dr. med. Dipl.-Math. (1) (-) Janz, Martin Dr. (5) (-) Sczakiel, Henrike (1) (-) Zauber, Henrik Dr. (1) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (5) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Genom-Editierung & Krankheitsmodelle (1) Integrative Vaskuläre Biologie (1) Kardiale MRT (5) Magnetic Resonance (3) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (2) Molekulare Herz- Kreislaufforschung (2) Pluripotent Stem Cells (1) Proteom Dynamik (3) Proteomics (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (1) 2015 (2) 2016 (2) 2017 (3) (-) 2018 (2) 2019 (3) 2020 (5) 2021 (3) 2022 (5) 2023 (7) 2024 (1) 6 Ergebnisse: Active Filter: Hinze, Christian Dr. med. Dipl.-Math.Janz, Martin Dr.Sczakiel, HenrikeZauber, Henrik Dr.Biologie maligner LymphomeGenom-Editierung & Krankheitsmodelle20062018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 20. September 2018 / Cell Mutations in disordered regions can cause disease by creating dileucine motifs K. Meyer M. Kirchner B. Uyar J.Y. Cheng G. Russo L.R. Hernandez-Miranda A. Szymborska H. Zauber I.M. Rudolph T.E. Willnow A. Akalin V. Haucke H. Gerhardt C. Birchmeier R. Kühn M. Krauss S. Diecke J.M. Pascual M. Selbach 01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
20. September 2018 / Cell Mutations in disordered regions can cause disease by creating dileucine motifs K. Meyer M. Kirchner B. Uyar J.Y. Cheng G. Russo L.R. Hernandez-Miranda A. Szymborska H. Zauber I.M. Rudolph T.E. Willnow A. Akalin V. Haucke H. Gerhardt C. Birchmeier R. Kühn M. Krauss S. Diecke J.M. Pascual M. Selbach
01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas